Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017)
Organogenesis Holdings' (ORGO) quarterly Income from Non-Controlling Interests came in at $273000.0 in Q2 2017, down 53.73% quarter-over-quarter from $590000.0 in Q1 2017.
Organogenesis Holdings (ORGO) Income from Non-Controlling Interests (2017) Analysis & Trends
Organogenesis Holdings' Income from Non-Controlling Interests history runs 1 years deep, the most recent figure standing at $273000.0 for Q2 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 395,346.10 |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -12.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Organogenesis Holdings | 323.97 Mn | 231.87 Mn | 11.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 273,000.00 |
| Mar 31, 2017 | 590,000.00 |